The Impact of Substance Abuse on Heart Failure Hospitalizations
- 29 July 2019
- journal article
- research article
- Published by Elsevier BV in The American Journal of Medicine
- Vol. 133 (2), 207-213.e1
- https://doi.org/10.1016/j.amjmed.2019.07.017
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health
This publication has 18 references indexed in Scilit:
- Timing and Causes of Readmission After Acute Heart Failure Hospitalization—Insights From the Heart Failure Network TrialsJournal of Cardiac Failure, 2016
- Methamphetamine-Associated Congestive Heart Failure: Increasing Prevalence and Relationship of Clinical Outcomes to Continued Use or AbstinenceCardiovascular Toxicology, 2015
- The Cardiac Complications of MethamphetaminesHeart, Lung and Circulation, 2015
- The Impact of Opioid Risk Reduction Initiatives on High-Dose Opioid Prescribing for Patients on Chronic Opioid TherapyThe Journal of Pain, 2015
- Influence of Previous Heart Failure Hospitalization on Cardiovascular Events in Patients With Reduced and Preserved Ejection FractionCirculation: Heart Failure, 2014
- Methamphetamine‐Associated CardiomyopathyClinical Cardiology, 2013
- Forecasting the Impact of Heart Failure in the United StatesCirculation: Heart Failure, 2013
- Lifetime Risk for Heart Failure Among White and Black AmericansJournal of the American College of Cardiology, 2013
- Rehospitalizations among Patients in the Medicare Fee-for-Service ProgramThe New England Journal of Medicine, 2009
- Readmission After Hospitalization for Congestive Heart Failure Among Medicare BeneficiariesArchives of Internal Medicine, 1997